(19)
(11) EP 3 452 077 A1

(12)

(43) Date of publication:
13.03.2019 Bulletin 2019/11

(21) Application number: 17793078.1

(22) Date of filing: 01.05.2017
(51) International Patent Classification (IPC): 
A61K 38/22(2006.01)
A61K 9/28(2006.01)
 A61K 9/00(2006.01)
A61K 47/38(2006.01)
(86) International application number:
PCT/US2017/030435
(87) International publication number:
WO 2017/192458 (09.11.2017 Gazette 2017/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 03.05.2016 US 201662331148 P
01.06.2016 US 201662344271 P

(71) Applicant: Spectrix Therapeutics, LLC
Southlake, TX 76092 (US)

(72) Inventor:
  • TENGLER, Mark
    Southlake, TX 76092 (US)

(74) Representative: Sonn & Partner Patentanwälte 
Riemergasse 14
1010 Wien
1010 Wien (AT)

   


(54) COMPOSITIONS AND METHODS OF PROVIDING THYROID HORMONE OR ANALOGS THEREOF